Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s.

Donoghue K, Medley I, Brewin J, Glazebrook C, Mason P, Cantwell R, Jones PB, Harrison G, Doody GA.

Soc Psychiatry Psychiatr Epidemiol. 2011 Feb;46(2):137-42. doi: 10.1007/s00127-009-0175-5. Epub 2009 Dec 31.

PMID:
20043146
2.

First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group.

Crebbin K, Mitford E, Paxton R, Turkington D.

Soc Psychiatry Psychiatr Epidemiol. 2009 Sep;44(9):710-5. doi: 10.1007/s00127-008-0490-2. Epub 2009 Jan 27.

PMID:
19183816
3.

Prevalence of substance misuse in first-episode psychosis.

Cantwell R, Brewin J, Glazebrook C, Dalkin T, Fox R, Medley I, Harrison G.

Br J Psychiatry. 1999 Feb;174:150-3.

PMID:
10211169
4.

Differential effects of sex on substance use between first episode psychosis patients and healthy people.

Núñez C, Ochoa S, Huerta-Ramos E, Baños I, Barajas A, Dolz M, Sánchez B, Del Cacho N; GENIPE Group., Usall J.

Compr Psychiatry. 2016 Aug;69:169-78. doi: 10.1016/j.comppsych.2016.05.017. Epub 2016 Jun 2.

PMID:
27423358
5.

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.

Hambrecht M, Häfner H.

Aust N Z J Psychiatry. 2000 Jun;34(3):468-75.

PMID:
10881971
6.

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.

Green AI, Tohen MF, Hamer RM, Strakowski SM, Lieberman JA, Glick I, Clark WS; HGDH Research Group..

Schizophr Res. 2004 Feb 1;66(2-3):125-35.

PMID:
15061244
7.

Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of research.

Kirkbride JB, Croudace T, Brewin J, Donoghue K, Mason P, Glazebrook C, Medley I, Harrison G, Cooper JE, Doody GA, Jones PB.

Int J Epidemiol. 2009 Oct;38(5):1255-64. doi: 10.1093/ije/dyn168. Epub 2008 Aug 25. Erratum in: Int J Epidemiol. 2009 Dec;38(6):1753.

8.

Substance misuse at presentation to an early psychosis program.

Van Mastrigt S, Addington J, Addington D.

Soc Psychiatry Psychiatr Epidemiol. 2004 Jan;39(1):69-72.

PMID:
15022049
9.

Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.

Frisher M, Crome I, Martino O, Croft P.

Schizophr Res. 2009 Sep;113(2-3):123-8. doi: 10.1016/j.schres.2009.05.031. Epub 2009 Jun 27.

PMID:
19560900
10.

Illicit substance use and its correlates in first episode psychosis.

Mazzoncini R, Donoghue K, Hart J, Morgan C, Doody GA, Dazzan P, Jones PB, Morgan K, Murray RM, Fearon P.

Acta Psychiatr Scand. 2010 May;121(5):351-8. doi: 10.1111/j.1600-0447.2009.01483.x. Epub 2009 Oct 13.

PMID:
19824986
11.

Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.

Sara GE, Burgess PM, Malhi GS, Whiteford HA, Hall WC.

Aust N Z J Psychiatry. 2014 Nov;48(11):1036-47. doi: 10.1177/0004867414533838. Epub 2014 May 12.

PMID:
24819935
12.

Prevalence of substance misuse among individuals with severe mental illness in São Paulo.

Rossi Menezes P, Ratto LR.

Soc Psychiatry Psychiatr Epidemiol. 2004 Mar;39(3):212-7.

PMID:
14999454
13.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
14.

Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.

Mané A, Fernández-Expósito M, Bergé D, Gómez-Pérez L, Sabaté A, Toll A, Diaz L, Diez-Aja C, Perez V.

Psychiatry Res. 2015 Sep 30;229(1-2):70-4. doi: 10.1016/j.psychres.2015.07.070. Epub 2015 Jul 28.

PMID:
26235479
15.

Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.

Ruiz-Veguilla M, Gurpegui M, Barrigón ML, Ferrín M, Marín E, Rubio JL, Gutiérrez B, Pintor A, Cervilla J.

Schizophr Res. 2009 Feb;107(2-3):158-64. doi: 10.1016/j.schres.2008.08.001. Epub 2008 Sep 21.

PMID:
18805673
16.

Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.

Faridi K, Pawliuk N, King S, Joober R, Malla AK.

Schizophr Res. 2009 Oct;114(1-3):57-63. doi: 10.1016/j.schres.2009.07.007. Epub 2009 Aug 9.

PMID:
19666214
17.

Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.

Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF.

Am J Psychiatry. 2009 Nov;166(11):1251-7. doi: 10.1176/appi.ajp.2009.09030311. Epub 2009 Oct 1.

18.

Comorbidity in psychosis at first hospitalization.

Strakowski SM, Tohen M, Stoll AL, Faedda GL, Mayer PV, Kolbrener ML, Goodwin DC.

Am J Psychiatry. 1993 May;150(5):752-7.

PMID:
8480821
19.

The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.

Moore E, Mancuso SG, Slade T, Galletly C, Castle DJ.

Aust N Z J Psychiatry. 2012 Sep;46(9):864-78. doi: 10.1177/0004867412443900. Epub 2012 Apr 3.

PMID:
22472772
20.

[Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment].

Gouzoulis-Mayfrank E.

Z Kinder Jugendpsychiatr Psychother. 2008 Jul;36(4):245-53. doi: 10.1024/1422-4917.36.4.245. Review. German.

PMID:
18654956

Supplemental Content

Support Center